Javier H. Ticona, Victoria M. Zaccone and Isabel M. McFarlane. Community-Acquired Pneumonia: A Focused Review.
. 2021; 9(1):45-52. doi: 10.12691/AJMCR-9-1-12
Community-acquired pneumonia (CAP), atypical pneumonia, typical pneumonia, procalcitonin, pneumonia severity index, CURB
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | Ramirez, J. A., Wiemken, T. L., Peyrani, P., Arnold, F. W., Kelley, R., Mattingly, W. A., et al. University of Louisville Pneumonia Study Group (2017). Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 65(11), 1806-1812. |
|
[2] | Christ-Crain, M., & Müller, B. (2007). Procalcitonin and pneumonia: Is it a useful marker? Current Infectious Disease Reports, 9(3), 233-240. |
|
[3] | Welte T. (2012). Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 31(1), 33-47. |
|
[4] | Kaysin, A., & Viera, A. J. (2016). Community-Acquired Pneumonia in Adults: Diagnosis and Management. American family physician, 94(9), 698-706. |
|
[5] | Xu, J., Murphy, S. L., Kochanek, K. D., & Bastian, B. A. (2016). Deaths: Final Data for 2013. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, 64(2), 1-119. |
|
[6] | Bjarnason, A., Westin, J., Lindh, M., Andersson, L. M., Kristinsson, K. G., Löve, A., Baldursson, O., & Gottfredsson, M. (2018). Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study. Open forum infectious diseases, 5(2) |
|
[7] | Griffin, M. R., Zhu, Y., Moore, M. R., Whitney, C. G., & Grijalva, C. G. (2013). U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination. New England Journal of Medicine, 369(2), 155-163. |
|
[8] | Cilloniz, C., Martin-Loeches, I., Garcia-Vidal, C., San Jose, A., & Torres, A. (2016). Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns. International Journal of Molecular Sciences, 17(12). |
|
[9] | Gupta, D., Agarwal, R., Aggarwal, A. N., Singh, N., Mishra, N., Khilnani, G. C., Samaria, J. K., Gaur, S. N., Jindal, S. K., & Pneumonia Guidelines Working Group (2012). Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. Lung India: official organ of Indian Chest Society, 29(Suppl 2), S27-S62. |
|
[10] | Rider, A. C., & Frazee, B. W. (2018). Community-Acquired Pneumonia. Emergency medicine clinics of North America, 36(4), 665-683. |
|
[11] | Murphy TF. Haemophilus species, Including H. influenzae and H. ducreyi (chancroid). In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th ed, Bennett JE, Dolin R, Blaser MJ (Eds), Elsevier, Philadelphia 2015. |
|
[12] | Steel, H. C., Cockeran, R., Anderson, R., & Feldman, C. (2013). Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease. Mediators of inflammation, 2013, 490346. |
|
[13] | Kaplan, V., Clermont, G., Griffin, M. F., Kasal, J., Watson, R. S., Linde-Zwirble, W. T., & Angus, D. C. (2003). Pneumonia: still the old man's friend?. Archives of internal medicine, 163(3), 317-323. |
|
[14] | Almirall, J., Serra-prat, B., et al. (2008). New evidence of risk factors for community-acquired pneumonia: a population-based study. European respiratory journal, 31: 1274-1284. |
|
[15] | Angele, Martin K., Frantz, Markus C., & Chaudry, Irshad H.. (2006). Gender and sex hormones influence the response to trauma and sepsis: potential therapeutic approaches. Clinics, 61(5), 479-488. |
|
[16] | Segreti, J., House, H. R., & Siegel, R. E. (2005). Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting. The American Journal of Medicine, 118(7), 21-28. |
|
[17] | Poirier, R., Rodrigue, J., Villeneuve, J., & Lacasse, Y. (2017). Early Radiographic and Tomographic Manifestations of Legionnaires’ Disease. Canadian Association of Radiologists Journal, 68(3), 328-333. |
|
[18] | Cunha, B. A., Burillo, A., & Bouza, E. (2016). Legionnaires’ disease. The Lancet, 387(10016), 376-385. |
|
[19] | Di Pasquale, M., Ferrer, M., Esperatti, M., Crisafulli, E., Giunta, V., Li Bassi, G., Rinaudo, M., Blasi, F., Niederman, M., & Torres, A. (2014). Assessment of severity of ICU-acquired pneumonia and association with etiology. Critical care medicine, 42(2), 303-312. |
|
[20] | Darden, D. B., Hawkins, R. B., Larson, S. D., Iovine, N. M., Prough, D. S., & Efron, P. A. (2020). The Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019. Critical care explorations, 2(4), e0109. |
|
[21] | Sibila, O., Laserna, E., Maselli, D. J., Fernandez, J. F., Mortensen, E. M., Anzueto, A., et al., (2015). Risk factors and antibiotic therapy in P.aeruginosa community-acquired pneumonia. Respirology, 20(4), 660-666. |
|
[22] | Kashyap, S., & Sarkar, M. (2010). Mycoplasma pneumonia: Clinical features and management. Lung India, 27(2), 75. |
|
[23] | Karakioulaki, M., Stolz, D. (2019). Biomarkers in Pneumonia: Beyond Procalcitonin. International Journal of Molecular Sciences, 20(8). |
|
[24] | Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., Griffin, M. R., Metersky, M. L., Musher, D. M., Restrepo, M. I., & Whitney, C. G. (2019). Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. American journal of respiratory and critical care medicine, 200(7). |
|
[25] | Almirall, J., Vidal, B., Coll, S., et al. (2000). Epidemiology of community-acquired pneumonia in adults: a population-based study. European respiratory journal, 15: 757-763. |
|
[26] | Dai, R. X., Kong, Q. H., Mao, B., Xu, W., Tao, R. J., Wang, X. R., Kong, Q. Y., & Xu, J. F. (2018). The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study. BMC pulmonary medicine, 18(1), 12. |
|
[27] | Braeken, D. C., Rohde, G. G., Franssen, F. M., Driessen, J. H., van Staa, T. P., Souverein, P. C., Wouters, E. F., & de Vries, F. (2017). Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom. International journal of chronic obstructive pulmonary disease, 12, 2425-2432. |
|